CLINICAL_TRIALS
trial_result
· 2026-01-07
Clinical Trial Update: Finerenone Therapy for Pediatric HSPN With Mild Proteinuria [Phase 4]
Summary
Phase 4 clinical trial evaluating finerenone for pediatric Henoch-Schönlein purpura nephritis with mild proteinuria; currently recruiting in China.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Capital Institute of Pediatrics, China | Conditions: Henoch Schönlein Purpura Nephritis | Phase 4 | Status: RECRUITING